Clinical Trial

Persistent COVID-19 Registry in Navarre.

Study acronym: PERSICOV-19
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 20, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to deepen our understanding of long COVID by determining the prevalence of the main complications and medium- to long-term sequelae of COVID-19 in Navarre. Sociodemographic variables such as age, sex, ethnicity, smoking history, and comorbidities will be collected, as well as clinical and disease management variables such as persistent COVID-19 symptoms at 3 months, all with the aim of characterizing patients with long COVID. All patient data will be collected in a single visit.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-11.
Trial Details
NCT Number NCT07417176
Lead Sponsor Fundacion Miguel Servet
Conditions Long COVID Symptoms, Long COVI
Enrollment 200 participants
Start Date 2021-01-04
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-20